Aortic Diseases
61
21
28
18
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
1 terminated out of 61 trials
94.7%
+8.2% vs benchmark
5%
3 trials in Phase 3/4
11%
2 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (61)
INFLATE Study: Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis
Effective Myocardial Protection Time of Del Nido Cardioplegia in Adult Cardiac Surgery
Use of Shockwave M5+/L6 IVL Catheter (Intravascular Lithotripsy) in Hostile and Calcified Iliac Access
Longitudinal Validation of CIRC Technologies
Impact of Aortic Diseases on Quality of Life and Work Ability
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
Cerebral Protection in Aortic Arch Surgery
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
PENG Block forTranscatheter Aortic Valve Implantation
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Antibiotic Prophylaxis for TEVAR
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
Aortic Dissection fAlse enlarGement radIomics predictiOn
ANATOMICAL FEASIBILITY OF BRAILE STANDARD BRANCHED ENDOGRAFT
Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts
Perceval Aortic Bioprostheses : Durability Study.
Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)
Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice